Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs
1m agoWillis launches Merger Protect to help manage M&A regulatory compliance costs
2m agoHawkins, Inc. to Release Fourth Quarter and Fiscal 2026 Financial Results on May 13, 2026
2m agoPurina Cat Chow Brings the Healing Power of Cats to College Campuses Across the Country
2m agoOnterris Earns 2026 E+E Leader Award for Innovation in Sustainability
Vivoryon Therapeutics N.v. logo

Vivoryon Therapeutics N.v.

About

Vivoryon Therapeutics N.v. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 23 2026
Vivoryon Therapeutics N.V. Reports Full Year 2025 Financial Results and Provides Business Update
Apr 15 2026
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
Apr 9 2026
Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference
Mar 28 2026
Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology
Jan 7 2026
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences

Community Chat

Ask AI

6ix6ix